Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Effect Modifications of Lipid-Lowering Therapy on Progression of Aortic Stenosis (from the Simvastatin and Ezetimibe in Aortic Stenosis [SEAS] Study)

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Causes of Mortality in the Marfan Syndrome(from a Nationwide Register Study)

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Usefulness of Transcatheter Aortic Valve Implantation for Treatment of Pure Native Aortic Valve Regurgitation

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Diagnostic Performance of Fully Automated Pixel-Wise Quantitative Myocardial Perfusion Imaging by Cardiovascular Magnetic Resonance

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. New-onset of postoperative atrial fibrillation is likely to recur in the absence of other triggers

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Antihypertensive Treatment With β-Blockade in Patients With Asymptomatic Aortic Stenosis and Association With Cardiovascular Events

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Early Gadolinium Enhancement for Determination of Area at Risk: A Preclinical Validation Study

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Risk stratifying asymptomatic aortic stenosis: Role of the resting 12-lead ECG

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Anders M. Greve
  • Casper N. Bang
  • Kurt Boman
  • Kenneth Egstrup
  • Julie L. Forman
  • Y. Antero Kesäniemi
  • Simon Ray
  • Terje R. Pedersen
  • Patricia Best
  • Nalini M. Rajamannan
  • Kristian Wachtell
View graph of relations

Observational studies indicate that low-density lipoprotein (LDL) cholesterol acts as a primary contributor to an active process leading to aortic stenosis (AS) development. However, randomized clinical trials have failed to demonstrate an effect of lipid lowering on impeding AS progression. This study explored if pretreatment LDL levels and AS severity altered the efficacy of lipid-lowering therapy. The study goal was evaluated in the analysis of surviving patients with baseline data in the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) trial of 1,873 asymptomatic patients with mild-to-moderate AS. Serially measured peak aortic jet velocity was the primary effect estimate. Linear mixed model analysis adjusted by baseline peak jet velocity and pretreatment LDL levels was used to assess effect modifications of treatment. Data were available in 1,579 (84%) patients. In adjusted analyses, lower baseline peak aortic jet velocity and higher pretreatment LDL levels increased the effect of randomized treatment (p = 0.04 for interaction). As such, treatment impeded progression of AS in the highest quartile of LDL among patients with mild AS at baseline (0.06 m/s per year slower progression vs placebo in peak aortic jet velocity, 95% confidence interval 0.01 to 0.11, p = 0.03), but not in the 3 other quartiles of LDL. Conversely, among patients with moderate AS, there was no detectable effect of treatment in any of the pretreatment LDL quartiles (all p ≥0.14). In conclusion, in a non–prespecified post hoc analysis, the efficacy of lipid-lowering therapy on impeding AS progression increased with higher pretreatment LDL and lower peak aortic jet velocity (SEAS study: NCT00092677).

Original languageEnglish
JournalAmerican Journal of Cardiology
Volume121
Issue number6
Pages (from-to)739-745
Number of pages7
ISSN0002-9149
DOIs
Publication statusPublished - 15 Mar 2018

ID: 55649729